Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | ONCOLOGY//CELL BIOLOGY//BIOCHEMISTRY & MOLECULAR BIOLOGY | 2934640 |
676 | 3 | CURCUMIN//CHALCONES//CURCUMINOIDS | 8980 |
3005 | 2 | CHALCONES//CLAISEN SCHMIDT CONDENSATION//CHALCONE DERIVATIVES | 2779 |
17576 | 1 | CROSSED ALDOL CONDENSATION//ALPHA ALPHA BISSUBSTITUTED BENZYLIDENECYCLOALKANONES//CROSS ALDOL CONDENSATION | 620 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | CROSSED ALDOL CONDENSATION | authKW | 650647 | 3% | 80% | 16 |
2 | ALPHA ALPHA BISSUBSTITUTED BENZYLIDENECYCLOALKANONES | authKW | 619663 | 3% | 76% | 16 |
3 | CROSS ALDOL CONDENSATION | authKW | 544081 | 3% | 63% | 17 |
4 | 4 PIPERIDONES | authKW | 508303 | 3% | 50% | 20 |
5 | PHARM NUTR | address | 401021 | 13% | 10% | 82 |
6 | DRUG DESIGN DISCOVERY GRP | address | 289159 | 3% | 36% | 16 |
7 | DRUG DISCOVERY DEV GRP | address | 220256 | 2% | 33% | 13 |
8 | 3 5 BISARYLIDENE 4 PIPERIDONES | authKW | 211800 | 1% | 83% | 5 |
9 | MURINE TOXICITY | authKW | 211800 | 1% | 83% | 5 |
10 | 3 5 BISBENZYLIDENE 4 PIPERIDONES | authKW | 203329 | 1% | 100% | 4 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Chemistry, Medicinal | 6942 | 31% | 0% | 195 |
2 | Chemistry, Organic | 1529 | 23% | 0% | 144 |
3 | Chemistry, Multidisciplinary | 1398 | 32% | 0% | 198 |
4 | Crystallography | 1302 | 13% | 0% | 79 |
5 | Pharmacology & Pharmacy | 472 | 18% | 0% | 112 |
6 | Chemistry, Inorganic & Nuclear | 8 | 2% | 0% | 15 |
7 | GREEN & SUSTAINABLE SCIENCE & TECHNOLOGY | 8 | 1% | 0% | 4 |
8 | Biochemistry & Molecular Biology | 5 | 8% | 0% | 47 |
9 | Spectroscopy | 3 | 1% | 0% | 8 |
10 | Education, Scientific Disciplines | 2 | 0% | 0% | 3 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | PHARM NUTR | 401021 | 13% | 10% | 82 |
2 | DRUG DESIGN DISCOVERY GRP | 289159 | 3% | 36% | 16 |
3 | DRUG DISCOVERY DEV GRP | 220256 | 2% | 33% | 13 |
4 | GOURISHANKAR EDUC SOC | 152497 | 0% | 100% | 3 |
5 | ALBERT SZENT GYORGYI MED XTR | 50832 | 0% | 100% | 1 |
6 | CELL CULTURE HIGH THROUGHPUT SCREENING IL | 50832 | 0% | 100% | 1 |
7 | CYTOMETRY IMAGING SCREENING CORE IL | 50832 | 0% | 100% | 1 |
8 | CYTOMETRY SCREENING IMAGING IL | 50832 | 0% | 100% | 1 |
9 | FORSKNINGPARKEN | 50832 | 0% | 100% | 1 |
10 | HUMAN BIOCHEM MED CHEM | 50832 | 0% | 100% | 1 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY | 9161 | 3% | 1% | 19 |
2 | EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY | 6314 | 6% | 0% | 35 |
3 | PHARMAZIE | 3511 | 4% | 0% | 25 |
4 | ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS | 2845 | 6% | 0% | 37 |
5 | ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH | 2643 | 2% | 1% | 10 |
6 | ARCHIV DER PHARMAZIE | 2262 | 2% | 0% | 14 |
7 | SYNTHETIC COMMUNICATIONS | 2195 | 4% | 0% | 25 |
8 | LETTERS IN DRUG DESIGN & DISCOVERY | 1690 | 1% | 0% | 7 |
9 | ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE | 1426 | 3% | 0% | 17 |
10 | GREEN CHEMISTRY LETTERS AND REVIEWS | 1241 | 0% | 1% | 3 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |